SKI Market

A+| A| A-|

Indian Indices

Sensex

76,226.43 811.08
( 1.08%)

Global Indices

Nasdaq

50,600.73 294.06
(0.58%)

Dow Jones

7,493.73 27.01
(0.36%)

Hang Seng

65,182.04 1,842.97
(2.91%)

Nikkei 225

10,474.02 30.55
(0.29%)

Forex

USD-INR

96.29 -0.42
(-0.43%)

EUR-INR

111.82 -0.44
(-0.39%)

GBP-INR

129.28 -0.40
(-0.31%)

JPY-INR

0.61 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

91669

INE0PLZ01012

36.3585943

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNREST

15.45

30.9

EPS(TTM)

Face Value()

Div & Yield %

2.33

Back

Aryaman Capital Markets standalone net profit rises 18.73% in the September 2025 quarter

Nov 13,2025

Net profit of Aryaman Capital Markets rose 18.73% to Rs 6.72 crore in the quarter ended September 2025 as against Rs 5.66 crore during the previous quarter ended September 2024. Sales declined 49.83% to Rs 10.43 crore in the quarter ended September 2025 as against Rs 20.79 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	10.43	20.79	-50
OPM %	75.46	37.33	-
PBDT	8.58	7.42	16
PBT	8.53	7.39	15
NP	6.72	5.66	19

76,226.43 811.08 ( 1.08%)

50,600.73 294.06 (0.58%)

7,493.73 27.01 (0.36%)

65,182.04 1,842.97 (2.91%)

10,474.02 30.55 (0.29%)

96.29 -0.42 (-0.43%)

111.82 -0.44 (-0.39%)

129.28 -0.40 (-0.31%)

0.61 0.00 (-0.48%)